AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. TBPH
  4. [Form 4] Theravance Biopharma, Inc. Insider Trading Activity

[Form 4] Theravance Biopharma, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock TBPH logo
Theravance Bioph

NASDAQ:TBPH

TBPH Rankings

#4415 Ranked by Market Cap
N/A Ranked by Dividends

TBPH Latest News

Jul 23, 2025
Theravance Biopharma to Participate in an Upcoming Investor Conference
Jun 26, 2025
Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA
Jun 2, 2025
Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million
May 13, 2025
Theravance Biopharma to Participate in an Upcoming Investor Conference
May 9, 2025
Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress

TBPH Latest SEC Filings

Jul 14, 2025
[144] Theravance Biopharma, Inc. SEC Filing
Jun 26, 2025
[8-K] Theravance Biopharma, Inc. Reports Material Event
Jun 25, 2025
[Form 4] Theravance Biopharma, Inc. Insider Trading Activity

TBPH Stock Data

576.52M
47.65M
6.22%
93.64%
7.54%
Biotechnology
Pharmaceutical Preparations
United States
GEORGE TOWN, GRAND CAYMAN